Finally, Australia-based international CRO Novotech is in the process of setting up a new management hub in the country's capital, which will supervise operations in Malaysia, Singapore, Thailand and the Philippines and serve as the base for expansion in the Asia-Pacific contract research sector. Malaysia will also benefit from the rising importance of bilateral trade and investment ties with China, which Chinese CRO Tigermed Consulting also recently partnering South Korean LSK, which will be responsible for operations in Malaysia, Taiwan, Japan and South Korea. Going forward, we expect the global financial crisis to further increase in Malaysia-China traffic over the near term, as consumers from developed countries cut back on spending, turning Malaysian exports towards regional economies to sell their output. Indeed, Malaysia is one of the six Association of Southeast Asian Nations (ASEAN) nations that will have their Most Favoured Nations (MFN) rates on Chinese goods reduced to 0% by 2010.
In tandem, the same trade rules apply to China, enabling more than 9,000 types of Malaysian goods to be duty-free, serving as a boon to Malaysias overall export sector, although the sizable Chinese generics industry will clearly halt penetration of Malaysia-made generics into China.
Key Topics Covered:
EXECUTIVE SUMMARY SWOT ANALYSIS PHARMACEUTICAL BUSINESS ENVIRONMENT RATINGS MALAYSIA MARKET SUMMARY REGULATORY REGIME INDUSTRY TRENDS AND DEVELOPMENTS INDUSTRY FORECAST SCENARIO COMPETITIVE LANDSCAPE COMPANY PROFILES COUNTRY SNAPSHOT: MALAYSIA DEMOGRAPHIC DATA METHODOLOGY FORECAST TABLESresearchandmarkets/research/3af99f/malaysia_pharmaceu